Nexthera Capital as of Dec. 31, 2016
Portfolio Holdings for Nexthera Capital
Nexthera Capital holds 39 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Shire | 13.0 | $22M | 130k | 170.38 | |
| Novartis (NVS) | 8.4 | $14M | 198k | 72.84 | |
| Celgene Corporation | 8.3 | $14M | 122k | 115.75 | |
| Alexion Pharmaceuticals | 7.2 | $12M | 100k | 122.35 | |
| Pfizer (PFE) | 6.1 | $10M | 318k | 32.48 | |
| AstraZeneca (AZN) | 4.8 | $8.2M | 300k | 27.32 | |
| Horizon Pharma | 4.7 | $8.1M | 500k | 16.18 | |
| Astrazeneca Plc option | 4.0 | $6.8M | 250k | 27.32 | |
| Tesaro | 3.9 | $6.7M | 50k | 134.48 | |
| Kite Pharma | 3.9 | $6.7M | 150k | 44.84 | |
| Alnylam Pharmaceuticals (ALNY) | 3.6 | $6.2M | 165k | 37.44 | |
| Minerva Neurosciences | 3.4 | $5.8M | 493k | 11.75 | |
| Neurocrine Biosciences (NBIX) | 2.7 | $4.6M | 120k | 38.70 | |
| Acceleron Pharma | 2.7 | $4.5M | 178k | 25.52 | |
| Insmed (INSM) | 2.5 | $4.3M | 322k | 13.23 | |
| Eiger Biopharmaceuticals | 1.8 | $3.1M | 264k | 11.65 | |
| Abeona Therapeutics | 1.6 | $2.8M | 569k | 4.85 | |
| Adamas Pharmaceuticals | 1.5 | $2.6M | 152k | 16.90 | |
| Fibrogen (FGEN) | 1.5 | $2.5M | 116k | 21.40 | |
| Trevena | 1.4 | $2.3M | 399k | 5.88 | |
| Cara Therapeutics (CARA) | 1.4 | $2.3M | 250k | 9.29 | |
| Newlink Genetics | 1.2 | $2.1M | 200k | 10.28 | |
| Ascendis Pharma A S (ASND) | 1.2 | $2.0M | 100k | 20.24 | |
| Zogenix | 1.1 | $1.8M | 150k | 12.15 | |
| Concert Pharmaceuticals I equity | 1.0 | $1.7M | 168k | 10.29 | |
| Sangamo Biosciences (SGMO) | 0.9 | $1.5M | 503k | 3.05 | |
| Paratek Pharmaceuticals | 0.9 | $1.5M | 100k | 15.40 | |
| Advaxis | 0.8 | $1.4M | 200k | 7.16 | |
| Axovant Sciences Ltd call | 0.7 | $1.2M | 100k | 12.42 | |
| Immune Design | 0.6 | $1.1M | 199k | 5.50 | |
| Clearside Biomedical (CLSD) | 0.6 | $1.1M | 121k | 8.94 | |
| Redhill Biopharma Ltd cmn | 0.6 | $994k | 95k | 10.46 | |
| Global Blood Therapeutics In | 0.5 | $867k | 60k | 14.45 | |
| Intec Pharma | 0.5 | $791k | 139k | 5.70 | |
| Vistagen Therapeutics | 0.3 | $515k | 138k | 3.73 | |
| Amicus Therapeutics | 0.3 | $497k | 100k | 4.97 | |
| Verastem | 0.2 | $376k | 336k | 1.12 | |
| Vascular Biogenics | 0.1 | $162k | 33k | 4.86 | |
| Tracon Pharmaceuticals | 0.0 | $62k | 13k | 4.88 |
